Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lorenzo Stramucci

Showing results (1-10 of 12) with videos related to

Pageof 2
Sort By:
Journal of Experimental & Clinical Cancer Research : CR|December 29, 2019
Approaching the challenges of MKK3/p38delta MAPK targeting for therapeutic purpose in colorectal cancerLorenzo Stramucci, Gianluca Bossi
Cancers|May 13, 2018
Insights of Crosstalk between p53 Protein and the MKK3/MKK6/p38 MAPK Signaling Pathway in CancerLorenzo Stramucci, Angelina Pranteda, Gianluca Bossi
Current Drug Targets|June 17, 2016
Cellular and Molecular Networks in Chronic Myeloid Leukemia: The Leukemic Stem, Progenitor and Stromal Cell InterplayDanilo Perrotti, Giovannino Silvestri, Lorenzo Stramucci, et al.
International Journal of Molecular Sciences|April 23, 2020
The p38 MAPK Signaling Activation in Colorectal Cancer upon Therapeutic TreatmentsAngelina Pranteda, Valentina Piastra, Lorenzo Stramucci, et al.
Journal of Immunology Research|August 7, 2015
Intradermal DNA Electroporation Induces Cellular and Humoral Immune Response and Confers Protection against HER2/neu TumorAlessia Lamolinara, Lorenzo Stramucci, Albana Hysi, et al.
Cell Death & Disease|November 8, 2019
MKK3 sustains cell proliferation and survival through p38DELTA MAPK activation in colorectal cancerLorenzo Stramucci, Angelina Pranteda, Arianna Stravato, et al.
Oncology Reports|July 8, 2022
Anti‑oncogenic and pro‑myogenic action of the MKK6/p38/AKT axis induced by targeting MEK/ERK in embryonal rhabdomyosarcomaAgnese Di Rocco, Simona Camero, Anna Benedetti, et al.
Journal of Immunology (Baltimore, Md. : 1950)|May 3, 2014
Multiple roles of perforin in hampering ERBB-2 (Her-2/neu) carcinogenesis in transgenic male miceMarco Macagno, Silvio Bandini, Lorenzo Stramucci, et al.
Plos One|April 5, 2013
Identification of relevant conformational epitopes on the HER2 oncoprotein by using Large Fragment Phage Display (LFPD)Federico Gabrielli, Roberto Salvi, Chiara Garulli, et al.
Nature Communications|March 17, 2017
The scaffold protein p140Cap limits ERBB2-mediated breast cancer progression interfering with Rac GTPase-controlled circuitriesSilvia Grasso, Jennifer Chapelle, Vincenzo Salemme, et al.
Pageof 2

Showing results (1-10 of 12) with videos related to

Sort By:
Pageof 2
Journal of Experimental & Clinical Cancer Research : CR|December 29, 2019
Approaching the challenges of MKK3/p38delta MAPK targeting for therapeutic purpose in colorectal cancerLorenzo Stramucci, Gianluca Bossi
Cancers|May 13, 2018
Insights of Crosstalk between p53 Protein and the MKK3/MKK6/p38 MAPK Signaling Pathway in CancerLorenzo Stramucci, Angelina Pranteda, Gianluca Bossi
Current Drug Targets|June 17, 2016
Cellular and Molecular Networks in Chronic Myeloid Leukemia: The Leukemic Stem, Progenitor and Stromal Cell InterplayDanilo Perrotti, Giovannino Silvestri, Lorenzo Stramucci, et al.
International Journal of Molecular Sciences|April 23, 2020
The p38 MAPK Signaling Activation in Colorectal Cancer upon Therapeutic TreatmentsAngelina Pranteda, Valentina Piastra, Lorenzo Stramucci, et al.
Journal of Immunology Research|August 7, 2015
Intradermal DNA Electroporation Induces Cellular and Humoral Immune Response and Confers Protection against HER2/neu TumorAlessia Lamolinara, Lorenzo Stramucci, Albana Hysi, et al.
Cell Death & Disease|November 8, 2019
MKK3 sustains cell proliferation and survival through p38DELTA MAPK activation in colorectal cancerLorenzo Stramucci, Angelina Pranteda, Arianna Stravato, et al.
Oncology Reports|July 8, 2022
Anti‑oncogenic and pro‑myogenic action of the MKK6/p38/AKT axis induced by targeting MEK/ERK in embryonal rhabdomyosarcomaAgnese Di Rocco, Simona Camero, Anna Benedetti, et al.
Journal of Immunology (Baltimore, Md. : 1950)|May 3, 2014
Multiple roles of perforin in hampering ERBB-2 (Her-2/neu) carcinogenesis in transgenic male miceMarco Macagno, Silvio Bandini, Lorenzo Stramucci, et al.
Plos One|April 5, 2013
Identification of relevant conformational epitopes on the HER2 oncoprotein by using Large Fragment Phage Display (LFPD)Federico Gabrielli, Roberto Salvi, Chiara Garulli, et al.
Nature Communications|March 17, 2017
The scaffold protein p140Cap limits ERBB2-mediated breast cancer progression interfering with Rac GTPase-controlled circuitriesSilvia Grasso, Jennifer Chapelle, Vincenzo Salemme, et al.
Pageof 2